TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2025
Back to search
Official data from USPTO
MISSION PHARMACAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/02/2025
Trademark type
Combined
Nice classes
5
Filing date
08/11/1997
Registration date
09/15/1998
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2018
Last transaction
04/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/1996
First use in commerce
01/01/1996
Drawing code
3
Owner type
03
Owner location
SAN ANTONIO, TX
Examiner
JACKSON, WILLIAM
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Mission Pharmacal Company
Mission Pharmacal Company
Representatives
Pamela B. Huff Schwegman Lundberg & Woessner P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical productsprophylactic drugs preventing calcium absorption by the human bodytherapeutic multivitamin combinationsorally administered dietary supplements of calcium saltorally administered dietary supplements of calcium salt with vitamin Dlaxativesanalgesic preparations for internal use or topical applicationantacid tablets for gastric hyperacidityantispasmodic treatmentshematinic tablets of ferrous gluconatetherapeutic flouridefolic acid tabletspreparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalanceorally administered sodium salt tabletshigh carbohydrate protein dietary food supplementspreparations for the treatment of secondary anemiapharmaceutical preparations in chewable tablet dosage formantispasmodicanticholinergicsantacidsantihistaminesantibioticsantiasmatics and antinauseasfor dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stonesfor surgical lubricating jellyvitamin and mineral preparations in liquid tablet and capsule formslow-release salt tabletsprophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stonesorally administered potassium phosphate preparations utilized for treatment of kidney stonespharmacuetical products prepared as an appetite depressant
Publications
History of USPTO decisions and trademark events.
33 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/27/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/03/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/18/2018
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/18/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/18/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/18/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/04/2018
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/19/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
03/13/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/15/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2017
CFIT
CASE FILE IN TICRS
05/16/2011
CFIT
CASE FILE IN TICRS
04/18/2011
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/29/2008
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/29/2008
PLGL
ASSIGNED TO PARALEGAL
08/28/2008
E89R
TEAS SECTION 8 & 9 RECEIVED
08/21/2008
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/23/2004
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/19/2004
E815
TEAS SECTION 8 & 15 RECEIVED
07/19/2004
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2003
PAPER RECEIVED
11/07/2002
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/1998
PUBO
PUBLISHED FOR OPPOSITION
06/23/1998
NPUB
NOTICE OF PUBLICATION
05/22/1998
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/1998
CNEA
EXAMINER'S AMENDMENT MAILED
04/06/1998
DOCK
ASSIGNED TO EXAMINER
03/23/1998
DOCK
ASSIGNED TO EXAMINER
03/19/1998
Continuous trademark protection
Get notified about every new filing that threatens MISSION PHARMACAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.